Year None20202019201820172016 October 26, 2020 Medicenna Presents Promising Preclinical Data on IL-2 and IL-13 Superkines at the EORTC-NCI-AACR Annual Meeting Go to October 26, 2020 Medicenna Presents Late Breaking Abstract Updating Results from Phase 2b Recurrent GBM Trial at the 36th EORTC-NCI-AACR Meeting Go to October 19, 2020 Medicenna Announces Upcoming Presentations at the EORTC-NCI-AACR Annual Meeting Go to October 15, 2020 Medicenna Provides MDNA55 rGBM Clinical Program Update Following Positive End of Phase 2 Meeting with the U.S. Food and Drug Administration (FDA) Go to September 30, 2020 Dr. Jack Geltosky Elected To Medicenna Board Of Directors Go to September 9, 2020 Medicenna to Present at Upcoming Investor Conferences in September Go to Pagination Current page 1 Page 2 Page 3 Page 4 Next page next › Last page last »
October 26, 2020 Medicenna Presents Promising Preclinical Data on IL-2 and IL-13 Superkines at the EORTC-NCI-AACR Annual Meeting Go to
October 26, 2020 Medicenna Presents Late Breaking Abstract Updating Results from Phase 2b Recurrent GBM Trial at the 36th EORTC-NCI-AACR Meeting Go to
October 19, 2020 Medicenna Announces Upcoming Presentations at the EORTC-NCI-AACR Annual Meeting Go to
October 15, 2020 Medicenna Provides MDNA55 rGBM Clinical Program Update Following Positive End of Phase 2 Meeting with the U.S. Food and Drug Administration (FDA) Go to
